Cite
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.
MLA
Jukema, J.Wouter, et al. “Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.” Journal of the American College of Cardiology, vol. 74, no. 9, Sept. 2019, pp. 1167–76. EBSCOhost, https://doi.org/10.1016/j.jacc.2019.03.013.
APA
Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., Karpov, Y., Moryusef, A., Pordy, R., Prieto, J. C., Roe, M. T., White, H. D., Zeiher, A. M., Schwartz, G. G., & Steg, P. G. (2019). Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial. Journal of the American College of Cardiology, 74(9), 1167–1176. https://doi.org/10.1016/j.jacc.2019.03.013
Chicago
Jukema, J Wouter, Michael Szarek, Laurien E Zijlstra, H Asita de Silva, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, et al. 2019. “Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.” Journal of the American College of Cardiology 74 (9): 1167–76. doi:10.1016/j.jacc.2019.03.013.